Stifel Initiates Coverage On Cogent Biosciences with Hold Rating, Announces Price Target of $16

Cogint, Inc. +2.96% Pre

Cogint, Inc.

COGT

33.42

33.42

+2.96%

0.00% Pre
Stifel analyst Laura Prendergast initiates coverage on Cogent Biosciences (NASDAQ: COGT) with a Hold rating and announces Price Target of $16.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via